Skip to content

Tony S.K. Mok

Beth Israel Deaconess Medical Center

2 papers in the Anchorcite directory, published between 2007 and 2009, cited 12,914 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Yi-Long Lung Cancer Wu · 1 paper
  • Sumitra Thongprasert · 1 paper
  • Da-Tong Chu · 1 paper
  • Nagahiro Saijo · 1 paper
  • Patrapim Sunpaweravong · 1 paper
  • Baohui Han · 1 paper
  • Benjamin Palgunadi Margono · 1 paper
  • Yukito Ichinose · 1 paper

Papers

  1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine · 2009 · 8,355 citations

    BACKGROUND: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer. METHODS: In this phase 3, open-label study, we randomly assigned previously untreated patients in East Asia who had advanced…

  2. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience · 2007 · 4,559 citations

    The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance…

Metadata from OpenAlex (CC0).